Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosteroneJUNG-HOFFMANN, C; KUHL, H.American journal of obstetrics and gynecology. 1987, Vol 156, Num 1, pp 199-203, issn 0002-9378Article

Intra- and interindividual variations in contraceptive steroid levels during 12 treatment cycles : no relation to irregular bleedingsJUNG-HOFFMANN, C; KUHL, H.Contraception (Stoneham). 1990, Vol 42, Num 4, pp 423-438, issn 0010-7824, 16 p.Article

Interaction with the pharmacokinetics of ethinylestradiol and progestogens contained in oral contraceptivesJUNG-HOFFMANN, C; KUHL, H.Contraception (Stoneham). 1989, Vol 40, Num 3, pp 299-312, issn 0010-7824Article

Serum concentrations of ethinylestradiol, 3-keto-desogestrel, SHBG, CBG and gonadotropins during treatment with a biphasic oral contraceptive containing desogestrelJUNG-HOFFMANN, C; STORCH, A; KUHL, H et al.Hormone research. 1992, Vol 38, Num 3-4, pp 184-189, issn 0301-0163Article

Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 μg ethinylestradiol and 75 μg gestodeneKUHL, H; JUNG-HOFFMANN, C; HEIDT, F et al.Contraception (Stoneham). 1988, Vol 38, Num 4, pp 477-486, issn 0010-7824Article

A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptivesADEN, U; JUNG-HOFFMANN, C; KUHL, H et al.Contraception (Stoneham). 1998, Vol 58, Num 2, pp 75-81, issn 0010-7824Article

Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteinsWIEGRATZ, I; JUNG-HOFFMANN, C; KUHL, H et al.Contraception (Stoneham). 1995, Vol 51, Num 6, pp 341-346, issn 0010-7824Article

Serum levels of 3-keto desogestrel and SHBG during 12 cycles of treatment with 30 μg ethinylestradiol and 150 μg desogestrelKUHL, H; JUNG-HOFFMANN, C; HEIDT, F et al.Contraception (Stoneham). 1988, Vol 38, Num 3, pp 381-390, issn 0010-7824Article

Oral contraceptive containing 20 or 30 μg ethinylestradiol and 150 μg desogestrel : pharmacokinetics and pharmacodynamic parametersJUNG-HOFFMANN, C; FITZNER, M; KUHL, H et al.Hormone research. 1991, Vol 36, Num 5-6, pp 238-246, issn 0301-0163Article

Effect of two oral contraceptives containing 30 μg ethynylestradiol and 75 μg gestodene or 150 g desogestrel upon various hormonal parametersJUNG-HOFFMANN, C; HEIDT, F; KUHL, H et al.Contraception (Stoneham). 1988, Vol 38, Num 6, pp 593-603, issn 0010-7824Article

Effect on lipid metabolism of a biphasic desogestrel-containing oral contraceptive : divergent changes in apolipoprotein B and E and transitory decrease in LP(a) levelsKUHL, H; MÄRZ, W; JUNG-HOFFMANN, C et al.Contraception (Stoneham). 1993, Vol 47, Num 1, pp 69-83, issn 0010-7824Article

Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parametersWIEGRATZ, I; JUNG-HOFFMANN, C; GROSS, W et al.Contraception (Stoneham). 1998, Vol 58, Num 2, pp 83-91, issn 0010-7824Article

The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parametersKUHL, H; JUNG-HOFFMANN, C; WEBER, J et al.Contraception (Stoneham). 1993, Vol 47, Num 1, pp 55-68, issn 0010-7824Article

Changes in lipid metabolism during 12 months of treatment with two oral contraceptives containing 30 μg ethinylestradiol and 75 μg gestodene or 150 μg desogestrelMAÊRZ, W; JUNG-HOFFMANN, C; HEIDT, F et al.Contraception (Stoneham). 1990, Vol 41, Num 3, pp 245-258, issn 0010-7824, 14 p.Article

Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptivesKUHL, H; MAÊRZ, W; JUNG-HOFFMANN, C et al.American journal of obstetrics and gynecology. 1990, Vol 163, Num 1, pp 363-369, issn 0002-9378, 7 p., . 2Article